GlassScriptPhysician profile
Kathryn Julia Bacci
NPI 1861075392
$1,240.76
in general payments reported to CMS, 2019-2025
25 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $250 · 2023: $302 · 2024: $172 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.05 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $289.17 | 2023-2025 | |
| Abbott Laboratories | $122.37 | 2023 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $120.06 | 2022 | |
| Intera Oncology, INC | $88.22 | 2025 | Intera |
| Silk Road Medical, INC. | $87.56 | 2022 | |
| Janssen Biotech, INC. | $84.99 | 2025 | Tremfya |
| Amgen INC. | $48.19 | 2022-2023 | Prolia, Evenity |
| Medtronic, INC. | $37.66 | 2024 | Synchromedii |
| Ethicon US, LLC | $34.66 | 2025 | Echelon Flex, Vistaseal |
| Embecta Corp. | $32.61 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Novo Nordisk INC | $30.50 | 2023-2024 | Sogroya |
| Acera Surgical, INC. | $25.57 | 2024 | Restrata Wound Matrix |
| Hologic Sales and Service, LLC | $23.01 | 2024 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $22.21 | 2025 | Entyvio |
| Tempus Ai, INC | $22.21 | 2025 | Xt Cdx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $21.26 | 2025 | Prevena |
| Corcept Therapeutics | $20.32 | 2023 | Korlym |
| Regeneron Healthcare Solutions, INC. | $19.55 | 2025 | Dupixent |
| Integra Lifesciences Corporation | $18.39 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astellas Pharma US INC | $18.36 | 2024 | |
| Ascendis Pharma Endocrinology INC | $16.81 | 2023 | |
| Daiichi Sankyo INC. | $16.17 | 2023 | |
| Ibsa Pharma INC. | $14.91 | 2022 | |
| Madrigal Pharmaceuticals | $13.81 | 2025 | Rezdiffra |
| Mallinckrodt Hospital Products INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Bacci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.